142 results
Page 5 of 8
6-K
EX-99.1
d57w5 6ahc8nv0srnuql
27 Feb 15
Live Filing
12:00am
6-K
EX-99.1
zmdxl ozqe
25 Feb 15
Live Filing
12:00am
6-K
EX-99.1
p391bc3
24 Feb 15
TEVA ANNOUNCES POSITIVE RESULTS FOR TEV-48125 IN PHASE IIb CHRONIC MIGRAINE STUDY MEETING PRIMARY AND SECONDARY ENDPOINTS
12:00am
6-K
EX-99.1
n4r79ry2p h37nax
23 Feb 15
Live Filing
12:00am
6-K
EX-99.1
nad93w897pvwrl0mu
20 Feb 15
Teva to Present New Respiratory Data at 2015 Annual Meeting of the American Academy of Allergy, Asthma and Immunology
12:00am
6-K
EX-99.1
1iw7cttu46vsn9bfca
5 Feb 15
Live Filing
12:00am
6-K
EX-99.1
8edd 9re5pfcdpqq05i
5 Feb 15
Teva Reports Fourth Quarter and Full Year 2014 Results
12:00am
6-K
EX-99.1
l1tspa1
26 Jan 15
Teva Receives Fda Approval for First Generic Nexium® Delayed-release Capsules In the United States
12:00am
6-K
EX-99.1
d43tszwg8
20 Jan 15
Teva Announces U.S. Supreme Court Decision to Reverse Federal Circuit Court’s Judgment on COPAXONE®20 mg/mL Case and Remand for Further Review
12:00am
6-K
EX-99.1
jx1f f3jippsc
7 Jan 15
Teva Launches Generic Diovan® In the United States
12:00am
6-K
EX-99.1
s49md1fh jnsuw
23 Dec 14
Live Filing
12:00am
6-K
EX-99.1
x4hct
19 Dec 14
First Waterless Nasal Allergy Spray Approved for Children as Young as Four Years of Age
12:00am
6-K
EX-99.1
wdtmz8etkrfz39yoj
11 Dec 14
Teva Announces Launch of First Generic Celebrex® Capsules In the United States
12:00am
6-K
EX-99.1
nt3aeu 4xhif
11 Dec 14
Teva Provides 2015 Business Outlook
12:00am
6-K
EX-99.1
of3pxr 0g00kk9
4 Dec 14
Live Filing
12:00am
6-K
EX-99.1
0w2a40
1 Dec 14
Live Filing
12:00am
6-K
EX-99.1
yt0nm3a
1 Dec 14
Teva Announces Launch of Generic Exforge HCT® Tablets In the United States
12:00am
6-K
EX-99.1
y5m7sh5txparuxg3za
26 Nov 14
Prof. Yitzhak Peterburg Elected Chairman of Teva’s Board of Directors
12:00am
6-K
EX-99.1
q6vgovbiwqmge
18 Nov 14
Live Filing
12:00am